Brent Aulston

About Brent Aulston

Brent Aulston, With an exceptional h-index of 7 and a recent h-index of 5 (since 2020), a distinguished researcher at University of California, San Diego, specializes in the field of Alzheimer's disease, diabetes.

His recent articles reflect a diverse array of research interests and contributions to the field:

Serine-129 phosphorylation of a-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function

Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function

In vivo safety and efficacy of a CRISPR‐based gene therapy for Alzheimer’s disease

Preclinical Research on CRISPR-Based Gene Editing for Alzheimer Disease Treatment: Brent D. Aulston, PhD.

Diminished neuronal ESCRT-0 function exacerbates AMPA receptor derangement and accelerates prion-induced neurodegeneration

Development of a MATLAB-based Toolkit to Quantify Neurodegenerative Histopathology Markers Applied to the Evaluation of a CRISPR-based Therapeutic for Alzheimer’s Disease (P3-6 …

Serine-129 phosphorylation of α-synuclein is a trigger for physiologic protein-protein interactions and synaptic function

Mutant presenilin 1 dysregulates exosomal proteome cargo produced by human-induced pluripotent stem cell neurons

Brent Aulston Information

University

Position

___

Citations(all)

187

Citations(since 2020)

163

Cited By

81

hIndex(all)

7

hIndex(since 2020)

5

i10Index(all)

6

i10Index(since 2020)

3

Email

University Profile Page

Google Scholar

Brent Aulston Skills & Research Interests

Alzheimer's disease

diabetes

Top articles of Brent Aulston

Serine-129 phosphorylation of a-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function

Neuron

2023/12/20

Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function

Neuron

2023/12/20

In vivo safety and efficacy of a CRISPR‐based gene therapy for Alzheimer’s disease

Alzheimer's & Dementia

2023/12

Preclinical Research on CRISPR-Based Gene Editing for Alzheimer Disease Treatment: Brent D. Aulston, PhD.

Neurology Live

2023/7/26

Diminished neuronal ESCRT-0 function exacerbates AMPA receptor derangement and accelerates prion-induced neurodegeneration

Journal of Neuroscience

2023/5/24

Development of a MATLAB-based Toolkit to Quantify Neurodegenerative Histopathology Markers Applied to the Evaluation of a CRISPR-based Therapeutic for Alzheimer’s Disease (P3-6 …

2023/4/25

Brent Aulston
Brent Aulston

H-Index: 6

Serine-129 phosphorylation of α-synuclein is a trigger for physiologic protein-protein interactions and synaptic function

bioRxiv

2022/12/23

Mutant presenilin 1 dysregulates exosomal proteome cargo produced by human-induced pluripotent stem cell neurons

ACS omega

2021/5/13

Dysregulation of exosome cargo by mutant tau expressed in human-induced pluripotent stem cell (iPSC) neurons revealed by proteomics analyses

Molecular & Cellular Proteomics

2020/6/1

See List of Professors in Brent Aulston University(University of California, San Diego)